Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BRL 37344 sodium
Cat. No.:
OB0425LY-007
Appearance:
Solid
Purity:
99.9%
Identity:
Confirmed by HPLC.
Size:
Add to basket
Product Overview
Description:
BRL 37344 sodium is a beta3 adrenergic receptor agonist, usually in the form of sodium salt. It has a significant regulatory effect on metabolic processes.
Synonyms:
127299-93-8; BRL 37344A; Acetic acid, 2-[4-[(2S)-2-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]-, sodium salt (1:1), rel-
CAS No.:
127299-93-8
Compound CID:
2436
Formula:
C19H21ClNNaO4
Formula Weight:
385.82
Specification
Target:
Adrenergic receptor
Pathway:
GPCR/G protein; Neuronal signaling
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
BRL 37344 sodium is widely used in metabolic disease research such as obesity, diabetes and its related diseases in drug development. Its use as a target can be used to develop new anti-obesity drugs.
